Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Prophylactic Fibrinogen Concentrate In Scoliosis Surgery
NCT05391412Phase 4Completed
- Sponsor
- Fakultní nemocnice Brno
- Start
- Jun 2022
- Primary completion
- Jul 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of Fibrinogen human in hemorrhage (2 arms), sponsored by Fakultní nemocnice Brno. Primary endpoints: Adverse event at 6 months, Adverse drug reaction at 6 months and 3 more. Started Jun 2022; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT05391412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05391412.